- Open Access
Use of human intra-tissue stem/progenitor cells and induced pluripotent stem cells for hair follicle regeneration
© The Author(s) 2019
- Received: 31 October 2018
- Accepted: 23 January 2019
- Published: 25 February 2019
The hair follicle (HF) is a unique miniorgan, which self-renews for a lifetime. Stem cell populations of multiple lineages reside within human HF and enable its regeneration. In addition to resident HF stem/progenitor cells (HFSPCs), the cells with similar biological properties can be induced from human-induced pluripotent stem cells (hiPSCs). As approaches to regenerate HF by combining HF-derived cells have been established in rodents and a huge demand exists to treat hair loss diseases, attempts have been made to bioengineer human HF using HFSPCs or hiPSCs.
Main body of the abstract
The aim of this review is to comprehensively summarize the strategies to regenerate human HF using HFSPCs or hiPSCs. HF morphogenesis and regeneration are enabled by well-orchestrated epithelial-mesenchymal interactions (EMIs). In rodents, various combinations of keratinocytes with mesenchymal (dermal) cells with trichogenic capacity, which were transplanted into in vivo environment, have successfully generated HF structures. The regeneration efficiency was higher, when epithelial or dermal HFSPCs were adopted. The success in HF formation most likely depended on high receptivity to trichogenic dermal signals and/or potent hair inductive capacity of HFSPCs. In theory, the use of epithelial HFSPCs in the bulge area and dermal papilla cells, their precursor cells in the dermal sheath, or trichogenic neonatal dermal cells should elicit intense EMI sufficient for HF formation. However, technical hurdles, represented by the limitation in starting materials and the loss of intrinsic properties during in vitro expansion, hamper the stable reconstitution of human HFs with this approach. Several strategies, including the amelioration of culture condition or compartmentalization of cells to strengthen EMI, can be conceived to overcome this obstacle. Obviously, use of hiPSCs can resolve the shortage of the materials once reliable protocols to induce wanted HFSPC subsets have been developed, which is in progress. Taking advantage of their pluripotency, hiPSCs may facilitate previously unthinkable approaches to regenerate human HFs, for instance, via bioengineering of 3D integumentary organ system, which can also be applied for the treatment of other diseases.
Further development of methodologies to reproduce bona fide EMI in HF formation is indispensable. However, human HFSPCs and hiPSCs hold promise as materials for human HF regeneration.
- Hair follicle
- Epithelial-mesenchymal interactions
- Stem cell
- Progenitor cell
- Induced pluripotent stem cell
In fact, human HF regeneration for treating non-autoimmune-mediated hair loss diseases, such as androgenetic alopecia or female pattern hair loss, may serve as an ideal model to probe the feasibility of regenerative medicine approaches for several reasons: (1) HF is easily accessible and observable; (2) HF morphogenesis, biology, and physiology have been well understood; (3) in vitro maintenance and cultivation of HF or HF-derived cells have been established; (4) at least in rodents, the methodologies to reconstitute HFs in vivo have been established; and (5) autologous transplantation of HFs in bald area has been widely conducted, etc. [3–6]. Of note, HF is a periodically self-renewing miniorgan harboring multiple stem/progenitor cell populations represented by epithelial HF stem cells (HFSCs) at the bulge area (Fig. 1c) and DP or its precursors in the dermal sheath (DS) (Fig. 1d), which serve as ideal cell sources for HF regeneration and, potentially for hiPSC generation [4–6]. Ultimately, HF-derived hiPSCs can be converted into HFSCs and unlimitedly supply materials for human HF regeneration .
Recent studies support the usefulness of hiPSCs to experimentally regenerate human HF [11–14]. The cell populations biologically resembling epithelial HFSCs or DP cells can be induced from hiPSCs [12, 14, 15]. Co-grafting with either component respectively with dermal or epithelial cells into in vivo environment resulted in HF-like structure formation. Furthermore, hiPSCs may enable previously unthinkable approaches to bioengineer HFs. For instance, taking advantage of their pluripotency, 3D integumentary organ system can be directly generated from hiPSCs .
The aim of this review is to summarize the strategies for using human HFSCs and progenitor cells or hiPSCs for HF regeneration with a particular emphasis on the enhancement of epithelial-mesenchymal interactions (EMIs).
Various approaches have been attempted to elicit EMIs sufficient for HF regeneration . However, all assays are based on the same principle; combining responder epithelial cells with inducer mesenchymal cells that are placed into a neutral permissive environment . A two-step approach consisting of in vitro experimentations to establish a condition to maximize EMIs and in vivo HF reconstitution assays adopting materials prepared in the condition optimized in vitro study would be beneficial [4, 5].
In vitro approaches
Organ culture of microdissected human HFs could be one of best approaches to monitor in vivo EMIs . However, HF isolation from the scalp sample can be laborious and the specimen is not readily available for all institutions.
More simply, HF keratinocytes (HFKCs) and DP, DS, or other trichogenic dermal cells (e.g., murine neonatal fibroblasts) can be co-cultured using cell inserts (Fig. 3a) [4, 5]. Epithelial and mesenchymal components crosstalk via shared culture medium with resultant HFKC proliferation, HFKC-related gene (e.g., KRT15, CD200, DIO2, GATA3, TRPS1, KRT75, MSX2) upregulation, or DP biomarker (e.g., ALPL, VCAN, LEF1, WNT5, NOG, SPRY4) expression within a couple of days [11, 17, 18]. Major drawback of this approach is the absence of direct intercompartmental crosstalk enabled by cell-cell contact.
In hair morphogenesis, focal thickening of the embryonic epidermis, i.e., hair placode, and DP precursors in the dermis communicate to initiate HF formation (Fig. 2). To mimic this situation in vitro, we are currently attempting to establish an assay in which trichogenic dermal cell or tested cell aggregates are embedded into the epidermal-dermal interface of three-dimensional human skin culture. A preliminary data suggests that the detection of some HF morphogenesis-related genes is possible under this experimental condition.
In vivo approaches
Whether or not this observation is applicable for human subjects has not been fully addressed. Although CD200 was identified as a cell surface marker, which enables the isolation of highly proliferative human bulge cells , the bulge cells obtainable from clinical samples are usually limited and insufficient to conduct even the patch assay. In addition, human epithelial HFSCs seemed to lose their intrinsic properties when they were cultured as demonstrated by the downregulation of signature genes, including keratin 15 , CD200 , Lhx2 , and Sox9 . How this affects their ability to communicate with mesenchymal cells needs to be appropriately investigated. However, unlike murine epithelial HFSCs, use of human counterpart to regenerate HFs is still technically challenging.
A possible approach to overcome this issue would be to increase the receptivity of KCs to trichogenic dermal signals by predisposing them to follicular fate. Activation of Wnt/β-catenin pathway may be a promising approach [36–38] as forced expression of β-catenin in the epidermis resulted in ectopic expression of hair keratins or de novo hair follicle formation in mice [39, 40]. Modulation of p63 expression in KCs may also enhance the response to trichogenic dermal message to the level analogous to that in HFSCs . Yet, an extreme caution needs to be paid for adopting these strategies for human HF regeneration, as aberrant expression of such genes may result in tumor formation. For instance, overactivation of β-catenin could give rise to pilomatricoma .
Amelioration of culture condition to maintain HFSC properties would be useful to prepare large number of HFSCs for HF bioengineering. A recent study demonstrated that murine HFSCs could be expanded maintaining their biological characteristics including high HF forming capacity when they were cultured three-dimensionally in Matrigel containing ROCK inhibitor (Y27632), FGF-2, and VEGF-A . How this methodology sustains human HFSC properties in vitro is still unclear and needs to be investigated in future studies.
An alternative approach to enhance KC receptivity to dermal signal is to use neonatal or embryonic KCs. Past in vivo grafting studies demonstrated that neonatal or fetal KCs were able to regenerate HF or HF-like structures [24, 44, 45]. Some HF-forming capacity could still be observed after cultivation of fetal cells. Apparently, this strategy cannot be directory adopted for clinical applications; however, these observations can drop a hint for enhancing EMIs for HF regeneration. Human adult KCs can reacquire some juvenile properties by basic fibroblast growth factors treatment . Likewise, exposure of KC to major factors playing key roles in the early phase of HF morphogenesis may allow KCs to exhibit HF forming cell (e.g., hair placode cell) phenotype. WNT, Ectodysplasin-A (EDA), BMP, and sonic hedgehog (SHH) signaling pathways are involved in HF placode formation [3, 8]. Either activation or suppression of these pathways in cultured KCs by supplementation of ligands could endow the cells with some HFSC properties. Feasibility of this approach is under investigation using human 3D skin equivalents and preliminary data suggested upregulation of several hair placode signature genes could be achieved.
Strategies to prepare DP cells while enhancing hair inductive capacity
DP cells are the most representative trichogenic dermal cells . Murine DP cells which can be efficiently isolated by cell sorter using genetically introduced fluorescent protein or CD133 as the cell surface marker [49–51], while human DP cells are usually manually microdissected from scalp samples (Fig. 6b) and expanded in vitro (Fig. 6c) before further experimentation as a specific surface marker is not readily available . The major problem of DP cell culture is, similar to that of KC culture, the loss of intrinsic properties during in vitro expansion [18, 52, 53] and various approaches have been attempted to overcome this hurdle.
In the bulb portion of HF, DP cells are maintained in a milieu of secreted ligands, growth factors, hormones, and extracellular matrices, which enables DP cells to crosstalk with HF matrix KCs and other cell subsets to sustain their properties . Significance of this EMI has been supported by the observation that the exposure to KC-conditioned medium facilitates DP cells to sustain their intrinsic properties, such as signature gene expression and, more importantly, hair inductive capacity [54, 55]. Thus, supplementation of DP cell activating factors missing in conventional culture medium could sustain/restore DP properties in vitro. In line with this speculation, agonist-driven activation of key signaling pathways, which were downregulated in DP cells during in vitro expansion, such as WNT, BMP, TGF-β2, and FGF signaling pathways, resulted in amelioration of murine and human DP properties [18, 53, 56–58]. The effect can be synergistically enhanced by combination of individual factors. For instance, dermal papilla activation culture condition (DPAC) containing WNT, BMP, and FGF agonists has been established to sustain or elicit human DP cell properties in culture (Fig. 6d). Transplantation of DPAC-treated human DP cells and human KCs into nude mice resulted in incomplete but distinguishable HF-like structure formation .
Aggregative behavior represents a major biological feature of DP cells [18, 59–62] (Fig. 4c). Most likely because cell aggregation restores cell-cell contact enabling better crosstalk between cells, three-dimensional culture can “reprograms” microenvironment of DP cells and ameliorate biological characteristics of cultured DP cells [18, 63]. Indeed, DP cell aggregates expressed higher levels of DP biomarkers and exhibit greater in vivo hair inductive capacity than non-aggregated cells [18, 59–61]. Several methodologies, such as hanging drop culture , forced cell aggregation by centrifuging in a low-cell binding plate [18, 59], and self-assembly on poly (ethylene-co-vinyl alcohol) (EVAL) membranes  have been reported to be effective in generating DP spheres with respective biological effects.
The observations described above suggested the possibility of overcoming technical obstacles which hamper the preparation of sufficient trichogenic human DP cells to trigger intense EMI by modulating culture condition . At the same time, currently available approaches would not allow preparation of fully competent human DP cells in vitro . Further improvements, including activation of SHH signaling pathway  or addition of DP-associated extracellular matrices (e.g., laminin, type IV collagen, fibronectin, olfactomedin, versican ), may be beneficial to achieve full reactivation of cultured human DP cells for HF bioengineering. Overexpression of transcription factors associated with HF neogenesis including Sox2 or Tbx18 [65, 66] in functionally impaired DP cells may provide strategy to restore mouse DP cells; however, such approach would not be suitable for clinical appreciations because of potential risk of tumorigenesis.
Preparation of DS cells as potential substitute for DP cells
Hair inductive capacity of DS cells, especially those in the proximal end of HF, has been demonstrated by various studies (summarized in ). DS tissue transplantation to amputated vibirissa HF restarted hair shaft production and implantation of human DS cells into the forearm skin of human recipient resulted in HF neogenesis [48, 67]. The classic observation that regeneration of DP in dissected upper two-third of vibrissa HFs  suggested that DS might contain DP stem cells or precursors, which was experimentally shown by in vivo fate mapping of DS cells . Thus, DS represents an alternative candidate to elicit EMI for HF regeneration. In fact, currently ongoing clinical study adopts DS “cup” cells adjacent to DP obtained from microdissected human HF for the treatment of androgenetic alopecia (https://replicel.com/patients/hair-study).
Elicitation of trichogenic activity in other mesenchymal cells
Neonatal mouse dermal fibroblasts have been routinely used in vivo HF reconstitution assay and are widely used for hair reconstitution assays [52, 70], implying that trichogenic capacity may be induced in mesenchymal cells other than DP or DS cells. Skin-derived precursor cells (SKPs) isolated from the dermis express Sox2 and nestin and shown to be trichogenic in mouse ; however, partly because isolation would be laborious, to what extent SKPs contribute to treatment of hair loss by HF regeneration is unclear. Adipose-derived stem cells (ASCs) could provide favorable cell source for various clinical applications. Rat ASCs can be combined with DP cells to form DP-like spheres, which exhibited superior DP characteristics than DP cell spheres . Introduction of platelet-derived growth factor-A, SOX2, and beta-catenin genes can endow ASCs hair inductive capacity . Instead of such genetic modifications, treatment of ASCs with a cocktail of apolipoprotein-A1, galectin-1, and lumican, the extracellular proteins overrepresented in embryonic perifolliculogenetic dermis , may enhance DP cell properties in ASCs.
Human-induced pluripotent stem cells (hiPSCs) hold great promise as material for regenerative medicine . Intriguingly, cellular components of HF, such as HFKCs, melanocytes, and DP cells, can be reprogrammed into hiPSCs (summarized in ). HFKCs efficiently give rise to hiPSCs, which can be further differentiated into other cell types to form functional structures, for instance, neural progenitors and neurons . DP cells and melanocytes express high levels of SOX2 [76, 77]. Murine DP cells also upregulate Klf4 and, taking advantage of intrinsic high expression of tow Yamanaka factors, can be differentiated into iPSCs with Oct4 alone . With current technology, four Yamanaka factors were indispensable to reprogram human DP cells into hiPSCs ; however, these findings support the idea of bioengineering large number of human HFs from a couple of HFs plucked from the scalp via generating hiPSCs and program those cells into HFKCs and DP cells. To date, several studies have reported the use of hiPSCs for the attempts to regenerate HF structures [11, 12, 14, 15].
Generation of HF epithelial cells from hiPSCs
Based on this hypothesis, we induced ectodermal precursor cells (EPCs) which were committed into KC lineage but not terminally differentiated and assessed if they were capable of communicating with DP cells and eventually contribute to HF formation in vivo . In our study, EPCs derived from hiPSCs generated with 4 or 3 Yamanaka factors (POU5F1, SOX2, KLF4 +/− MYC) expressing keratin 14 and 18 were successfully obtained by the use of RA and BMP4 and KC culture medium. One out of three hiPSC-EPC lines more strongly upregulated HFKC markers than normal human adult KCs (NHKCs), when co-cultured with human DP cells. At the same time, DP cells increased some DP biomarker expression in response to coexisting EPCs. These findings supported that hiPSCs-derived EPCs were capable of eliciting intense EMIs with DP cells. When mixed with trichogenic mice dermal cells and transplanted into nude mice, hiPSC-EPCs, but not NHKCs, partially contributed to regenerated HF structures in the patch assay experiments .
Human epithelial HFSCs highly express cell surface markers, such as CD200 and ITGA6 [12, 33]. With some modification to the KC induction protocol followed by selective cell sorting of CD200(+)ITGA6(+) subset, Yang et al. successfully generated epithelial HFSCs . When co-grated with mouse neonatal dermal cells in the chamber assay, generated cells were capable of regenerating HF structures and repopulating into all HF lineages. Moreover, hiPSC-derived HFKCs were shown to differentiate into sebocytes in vitro and reconstituted interfollicur epidermis, indicating their multipotency . These observations indicate that hiPSCs provide materials for the generation of HFSCs with high receptivity to trichogenic dermal signals, which facilitate intense EMIs sufficient for HF bioengineering.
Generation of DP cells or equivalents from hiPSCs
DP is the vital mesenchymal component for HF morphogenesis and regeneration. However, as mentioned above, currently available approach would not allow preparation of fully functional DP cells for human HF bioengineering urging us to develop a protocol for generating DP or equivalent cells with trichogenicity in vivo .
Generation of mesenchymal cells (MCs) with some plasticity from iPSCs has been reported [80, 81]. Thus, we first attempted to establish a methodology to induce MCs with SC properties  (Fig. 7). Use of mesenchymal stem cell medium containing PDGF, TGF-β, and FGF enabled the induction of hiPSCs into MCs. LNGFR(+)THY-1(+) subset were subsequently isolated form the induced cell population, which were shown to be highly proliferative and with the capacity to differentiate into osteoblast, adipocyte, and chondrocyte, supporting their mesenchymal SC-like properties . When exposed to RA followed by DPAC in vitro, LNGFR(+)THY-1(+) MCs upregulated some DP biomarkers such as ALPL, WIF1, HEY1, WNT5A, GUCY1A3, and LRP4 and were able to bidirectionally communicate with human KCs in co-culture to increase DP and HFKC markers in themselves and KCs respectively (Fig. 7). Importantly, when co-transplanted with human KCs, RA-DPAC-treated LNGFR(+)THY-1(+) MCs gave rise to HF-like structures . Regenerated HF-like structures recapitulated some HF characteristics, including HF-specific marker expression, but were morphologically incomplete and infrequently regenerated. These findings clearly demonstrated that further investigation is necessary to fully establish the methodology to generate DP cells from hiPSCs.
Possible strategies to accomplish this goal include the modification in differentiation protocol including further amelioration of DPAC. Considering that DP cells in the craniofacial area originate from the neural crest [83, 84], induction of DP cells via neural crest cell lineage would be an alternative approach . Taking advantage of this approach, successful HF regeneration using iPS cell-derived epithelial and mesenchymal component has been presented (by Prof. OhSang Kwon, Department of Dermatology, Seoul National University at the World Congress of Hair Research 2017, Kyoto, Japan). The work should move the field forward, when the detailed information is officially published.
Regeneration of HFs via bioengineered 3D integumentary organ
A unique approach taking full advantage of hiPSCs was recently reported (Fig. 7) . In the study by Takagi and colleagues, 3D integumentary organ system (IOS) was efficiently generated from murine gingiva-derived iPSCs by a transplantation method in which more than 30 embryoid bodies (EBs) were embedded in collagen gel and transplanted into subrenal capsule of severe combined immunodeficient mice . This method allowed formation of cystic areas in transplants at higher ratio than those generated from single iPSC or EB transplants. Intriguingly, 3D IOS, including the skin, HFs, dermis, sebaceous glands, and subcutaneous tissue, were formed at high frequency in explants by CDB transplantation method. In addition, Wnt10b-treatment increased the efficiency of mature HF formation in explants. 3D IOS can be transplanted onto the back of nude mice and regenerated full skin structures containing HFs with normal hair subtype ratio, spacing, and hair cycles. To what extent this new technology is applicable to human iPSCs needs to be further examined. However, this novel approach may enhance opportunity for successful reconstruction of complicated structures from hiPSCs, represented by HFs.
Future direction of HF bioengineering from hiPSCs
All currently available approaches using iPSCs mentioned above requires in vivo environment to form HF structures [11–15]. Even if HFs of acceptable morphology were successfully made, direct transplantation of regenerated structures into hair loss area of patients is still technically challenging. Reproduction of complete HF structures seems to be straightforward to treat hair loss; however, HF structures are damaged/miniaturized but not lost in the majority of hair loss disorders . Thus, preparation of cell population which supports HF enlargement via cell autonomous or non-autonomous mechanisms, e.g., incorporation into DP or secreting growth factors or activating ligands for signaling pathways crucial for HF neogenesis, could be more practical and cost-friendly approaches which are achievable without in vivo environment . As the width of the hair shafts correlates with the size of DP , induction of DS cells with DP precursor cell capacity to repopulate to DP or the cells that constitutively secrete hair growth-promoting factors induced from hiPSCs may represent promising future strategy for the treatment of hair loss diseases. Recent observations, such as restoration of damaged HF in a mouse model with humanized scalp by human DP and DS cells, initiation of new anagen by extracellular vesicles derived from mesenchymal SCs activated DP cells in mice, and promotion of human HF growth by ASCs and their secretary factors [87–89] suggested the possibility of similar approaches using hiPSCs.
It should be noted that the need for regeneration of complete human HF structure is still present. For some types of non-autoimmune-mediated permanent hair loss, represented by scaring alopecia secondary to trauma, burn, or irradiation, and extensive male or female pattern hair loss, transplantation of regenerated HFs would be the only treatment option. For clinical application, in vivo HF reconstitution using immunodeficient mice wound not be preferable mainly because of biosafety. Establishment of in vitro construction of functional HF structures by means of 3D molding (Fig. 3d, e) or IOS (Fig. 7) using hiPSCs-derived HF cells (and possibly HFSPCs as well) is required. The size of bioengineered HFs may be enlarged by the cell-based supplementation strategies as described above.
Possible application of HFSPCs or hiPSCs-derived HF cells in regenerative medicine
The techniques to better prepare or maintain fully functional HFSPCs or hiPSCs-derived HF cells could also be applied to regenerative medicine for other diseases. In addition to multipotent bulge epithelial HFSPCs capable of repopulating HFs, the epidermis, and sebaceous glands  , DS cells can be more preferential cell source than dermal fibroblast in the preparation of 3D skin equivalent . Therefore, HFSPCs or hiPSCs-derived HF cells may provide better materials for whole skin regeneration. DP and DS cells were shown to differentiate into hematopoietic, adipogenic, and osteogenic lineages [91, 92]. DP and DS cells supported embryonic stem cells and iPSC maintenance and hematopoiesis in vitro . Furthermore, DS cells exhibited immunosuppressive role to improve islet allograft survival in the mouse model of type Ι diabetes . These observations suggest that HFSPCs or hiPSCs-derived HF cells may provide favorable materials in regenerative medicine not limited to HF bioengineering.
The advances have been made in the identification of stem/progenitor cell subsets within HFs. Various techniques to enhance EMI and regenerate HFs adopting these subsets have been developed. However, most investigations were conducted in mice. We are aware that mice and human HF cells share fundamental biological properties but they are distinct . Major morphological and physiological characteristics, such as size and hair cycle, are also different between mouse and human HFs [4, 14]. Seemingly, theoretical basis for human HF regeneration have already been developed, yet a pile of problems still remain unsolved before human HF bioengineering becomes truly possible. The wise use of hiPSCs may enhance opportunity to overcome major technical hurdles and enable better understanding of HF biology, drug discovery, and, ultimately, replacement therapy for intractable hair disorders, which can further be applied to treat other tackling diseases.
The author would like to thank Prof. Hideyuki Okano and Prof. Kenji Kabashima for granting an opportunity to write this review and all laboratory members and collaborators for technical assistance.
Writing of this manuscript and the experimentations of the preliminary studies mentioned are supported in part by JSPS KAKENHI (Grant Number JP 16H05370 to MO).
Availability of data and materials
MO wrote this paper, read, and approved the final manuscript.
Ethics approval and consent to participate
Consent for publication
The author declares that he has no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Stenn KS, Paus R. Controls of hair follicle cycling. Physiol Rev. 2001;81(1):449–94.PubMedGoogle Scholar
- Nagao K, Kobayashi T, Moro K, Ohyama M, Adachi T, Kitashima DY, Ueha S, Horiuchi K, Tanizaki H, Kabashima K, et al. Stress-induced production of chemokines by hair follicles regulates the trafficking of dendritic cells in skin. Nat Immunol. 2012;13(8):744–52.PubMedPubMed CentralGoogle Scholar
- Sennett R, Rendl M. Mesenchymal-epithelial interactions during hair follicle morphogenesis and cycling. Semin Cell Dev Biol. 2012;23(8):917–27.PubMedPubMed CentralGoogle Scholar
- Ohyama M, Veraitch O. Strategies to enhance epithelial-mesenchymal interactions for human hair follicle bioengineering. J Dermatol Sci. 2013;70(2):78–87.PubMedGoogle Scholar
- Ohyama M, Zheng Y, Paus R, Stenn KS. The mesenchymal component of hair follicle neogenesis: background, methods and molecular characterization. Exp Dermatol. 2010;19(2):89–99.PubMedGoogle Scholar
- Yang CC, Cotsarelis G. Review of hair follicle dermal cells. J Dermatol Sci. 2010;57(1):2–11.PubMedPubMed CentralGoogle Scholar
- Ohyama M, Okano H. Promise of human induced pluripotent stem cell in skin regeneration and investigation. J Invest Dermatol. 2013;134(3):605–9.PubMedGoogle Scholar
- Millar SE. Molecular mechanisms regulating hair follicle development. J Invest Dermatol. 2002;118(2):216–25.PubMedGoogle Scholar
- Morris RJ, Liu Y, Marles L, Yang Z, Trempus C, Li S, Lin JS, Sawicki JA, Cotsarelis G. Capturing and profiling adult hair follicle stem cells. Nat Biotechnol. 2004;22(4):411–7.PubMedGoogle Scholar
- Blanpain C, Lowry WE, Geoghegan A, Polak L, Fuchs E. Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche. Cell. 2004;118(5):635–48.PubMedGoogle Scholar
- Veraitch O, Kobayashi T, Imaizumi Y, Akamatsu W, Sasaki T, Yamanaka S, Amagai M, Okano H, Ohyama M. Human induced pluripotent stem cell-derived ectodermal precursor cells contribute to hair follicle morphogenesis in vivo. J Invest Dermatol. 2013;133(6):1479–88.PubMedGoogle Scholar
- Yang R, Zheng Y, Burrows M, Liu S, Wei Z, Nace A, Guo W, Kumar S, Cotsarelis G, Xu X. Generation of folliculogenic human epithelial stem cells from induced pluripotent stem cells. Nat. Commun. 2014;5:3071.PubMedPubMed CentralGoogle Scholar
- Takagi R, Ishimaru J, Sugawara A, Toyoshima KE, Ishida K, Ogawa M, Sakakibara K, Asakawa K, Kashiwakura A, Oshima M, et al. Bioengineering a 3D integumentary organ system from iPS cells using an in vivo transplantation model. Sci Adv. 2016;2(4):e1500887.PubMedPubMed CentralGoogle Scholar
- Veraitch O, Mabuchi Y, Matsuzaki Y, Sasaki T, Okuno H, Tsukashima A, Amagai M, Okano H, Ohyama M. Induction of hair follicle dermal papilla cell properties in human induced pluripotent stem cell-derived multipotent LNGFR(+)THY-1(+) mesenchymal cells. Sci Rep. 2017;7(42777):42777.PubMedPubMed CentralGoogle Scholar
- Gnedeva K, Vorotelyak E, Cimadamore F, Cattarossi G, Giusto E, Terskikh VV, Terskikh AV. Derivation of hair-inducing cell from human pluripotent stem cells. PLoS One. 2015;10(1):e0116892.PubMedPubMed CentralGoogle Scholar
- Philpott MP, Green MR, Kealey T. Human hair growth in vitro. J Cell Sci. 1990;97(Pt 3):463–71.PubMedGoogle Scholar
- Inui S, Fukuzato Y, Nakajima T, Yoshikawa K, Itami S. Androgen-inducible TGF-beta1 from balding dermal papilla cells inhibits epithelial cell growth: a clue to understand paradoxical effects of androgen on human hair growth. FASEB J. 2002;16(14):1967–9.PubMedGoogle Scholar
- Ohyama M, Kobayashi T, Sasaki T, Shimizu A, Amagai M. Restoration of the intrinsic properties of human dermal papilla in vitro. J Cell Sci. 2012;125(Pt 17):4114–25.PubMedGoogle Scholar
- Havlickova B, Biro T, Mescalchin A, Tschirschmann M, Mollenkopf H, Bettermann A, Pertile P, Lauster R, Bodo E, Paus R. A human folliculoid microsphere assay for exploring epithelial-mesenchymal interactions in the human hair follicle. J Invest Dermatol. 2009;129(4):972–83.PubMedGoogle Scholar
- Yen CM, Chan CC, Lin SJ. High-throughput reconstitution of epithelial-mesenchymal interaction in folliculoid microtissues by biomaterial-facilitated self-assembly of dissociated heterotypic adult cells. Biomaterials. 2010;31(15):4341–52.PubMedGoogle Scholar
- Lindner G, Horland R, Wagner I, Atac B, Lauster R. De novo formation and ultra-structural characterization of a fiber-producing human hair follicle equivalent in vitro. J Biotechnol. 2011;152(3):108–12.PubMedGoogle Scholar
- Toyoshima KE, Asakawa K, Ishibashi N, Toki H, Ogawa M, Hasegawa T, Irie T, Tachikawa T, Sato A, Takeda A, et al. Fully functional hair follicle regeneration through the rearrangement of stem cells and their niches. Nat. Commun. 2012;3:784.PubMedPubMed CentralGoogle Scholar
- Jahoda CA, Oliver RF, Reynolds AJ, Forrester JC, Gillespie JW, Cserhalmi-Friedman PB, Christiano AM, Horne KA. Trans-species hair growth induction by human hair follicle dermal papillae. Exp Dermatol. 2001;10(4):229–37.PubMedGoogle Scholar
- Ehama R, Ishimatsu-Tsuji Y, Iriyama S, Ideta R, Soma T, Yano K, Kawasaki C, Suzuki S, Shirakata Y, Hashimoto K, et al. Hair follicle regeneration using grafted rodent and human cells. J Invest Dermatol. 2007;127(9):2106–15.PubMedGoogle Scholar
- Inoue K, Kato H, Sato T, Osada A, Aoi N, Suga H, Eto H, Gonda K, Yoshimura K. Evaluation of animal models for the hair-inducing capacity of cultured human dermal papilla cells. Cells Tissues Organs. 2009;190(2):102–10.PubMedGoogle Scholar
- Oshima H, Rochat A, Kedzia C, Kobayashi K, Barrandon Y. Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell. 2001;104(2):233–45.PubMedGoogle Scholar
- Nijhof JG, Braun KM, Giangreco A, van Pelt C, Kawamoto H, Boyd RL, Willemze R, Mullenders LH, Watt FM, de Gruijl FR, et al. The cell-surface marker MTS24 identifies a novel population of follicular keratinocytes with characteristics of progenitor cells. Development. 2006;133(15):3027–37.PubMedGoogle Scholar
- Jensen KB, Collins CA, Nascimento E, Tan DW, Frye M, Itami S, Watt FM. Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis. Cell Stem Cell. 2009;4(5):427–39.PubMedPubMed CentralGoogle Scholar
- Jaks V, Barker N, Kasper M, van Es JH, Snippert HJ, Clevers H, Toftgard R. Lgr5 marks cycling, yet long-lived, hair follicle stem cells. Nat Genet. 2008;40(11):1291–9.PubMedGoogle Scholar
- Snippert HJ, Haegebarth A, Kasper M, Jaks V, van Es JH, Barker N, van de Wetering M, van den Born M, Begthel H, Vries RG, et al. Lgr6 marks stem cells in the hair follicle that generate all cell lineages of the skin. Science. 2010;327(5971):1385–9.PubMedGoogle Scholar
- Cotsarelis G, Sun TT, Lavker RM. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell. 1990;61(7):1329–37.PubMedGoogle Scholar
- Lyle S, Christofidou-Solomidou M, Liu Y, Elder DE, Albelda S, Cotsarelis G. The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J Cell Sci. 1998;111(Pt 21):3179–88.PubMedGoogle Scholar
- Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB, Brady JN, Udey MC, Vogel JC. Characterization and isolation of stem cell-enriched human hair follicle bulge cells. J Clin Invest. 2006;116(1):249–60.PubMedPubMed CentralGoogle Scholar
- Rhee H, Polak L, Fuchs E. Lhx2 maintains stem cell character in hair follicles. Science. 2006;312(5782):1946–9.PubMedPubMed CentralGoogle Scholar
- Nowak JA, Polak L, Pasolli HA, Fuchs E. Hair follicle stem cells are specified and function in early skin morphogenesis. Cell Stem Cell. 2008;3(1):33–43.PubMedPubMed CentralGoogle Scholar
- Millar SE, Willert K, Salinas PC, Roelink H, Nusse R, Sussman DJ, Barsh GS. WNT signaling in the control of hair growth and structure. Dev Biol. 1999;207(1):133–49.PubMedGoogle Scholar
- Andl T, Reddy ST, Gaddapara T, Millar SE. WNT signals are required for the initiation of hair follicle development. Dev Cell. 2002;2(5):643–53.PubMedGoogle Scholar
- Ito M, Yang Z, Andl T, Cui C, Kim N, Millar SE, Cotsarelis G. Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature. 2007;447(7142):316–20.PubMedGoogle Scholar
- Gat U, DasGupta R, Degenstein L, Fuchs E. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell. 1998;95(5):605–14.PubMedGoogle Scholar
- Suzuki K, Yamaguchi Y, Villacorte M, Mihara K, Akiyama M, Shimizu H, Taketo MM, Nakagata N, Tsukiyama T, Yamaguchi TP, et al. Embryonic hair follicle fate change by augmented beta-catenin through Shh and Bmp signaling. Development. 2009;136(3):367–72.PubMedGoogle Scholar
- Truong AB, Kretz M, Ridky TW, Kimmel R, Khavari PA. p63 regulates proliferation and differentiation of developmentally mature keratinocytes. Genes Dev. 2006;20(22):3185–97.PubMedPubMed CentralGoogle Scholar
- Chan EF, Gat U, McNiff JM, Fuchs E. A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet. 1999;21(4):410–3.PubMedGoogle Scholar
- Chacon-Martinez CA, Klose M, Niemann C, Glauche I, Wickstrom SA. Hair follicle stem cell cultures reveal self-organizing plasticity of stem cells and their progeny. EMBO J. 2017;36(2):151–64.PubMedGoogle Scholar
- Thangapazham RL, Klover P, Li S, Wang JA, Sperling L, Darling TN. A model system to analyse the ability of human keratinocytes to form hair follicles. Exp Dermatol. 2014;23(6):443–6.PubMedGoogle Scholar
- Wu X, Scott L Jr, Washenik K, Stenn K. Full-thickness skin with mature hair follicles generated from tissue culture expanded human cells. Tissue Eng Part A. 2014;20(23–24):3314–21.PubMedGoogle Scholar
- Sun X, Fu X, Han W, Zhao Y, Liu H, Sheng Z. Dedifferentiation of human terminally differentiating keratinocytes into their precursor cells induced by basic fibroblast growth factor. Biol Pharm Bull. 2011;34(7):1037–45.PubMedGoogle Scholar
- Oliver RF. The experimental induction of whisker growth in the hooded rat by implantation of dermal papillae. J Embryol Exp Morphol. 1967;18(1):43–51.PubMedGoogle Scholar
- Reynolds AJ, Lawrence C, Cserhalmi-Friedman PB, Christiano AM, Jahoda CA. Trans-gender induction of hair follicles. Nature. 1999;402(6757):33–4.PubMedGoogle Scholar
- Kishimoto J, Ehama R, Wu L, Jiang S, Jiang N, Burgeson RE. Selective activation of the versican promoter by epithelial- mesenchymal interactions during hair follicle development. Proc Natl Acad Sci U S A. 1999;96(13):7336–41.PubMedPubMed CentralGoogle Scholar
- Rendl M, Lewis L, Fuchs E. Molecular dissection of mesenchymal-epithelial interactions in the hair follicle. PLoS Biol. 2005;3(11):e331.PubMedPubMed CentralGoogle Scholar
- Ito Y, Hamazaki TS, Ohnuma K, Tamaki K, Asashima M, Okochi H. Isolation of murine hair-inducing cells using the cell surface marker prominin-1/CD133. J Invest Dermatol. 2007;127(5):1052–60.PubMedGoogle Scholar
- Weinberg WC, Goodman LV, George C, Morgan DL, Ledbetter S, Yuspa SH, Lichti U. Reconstitution of hair follicle development in vivo: determination of follicle formation, hair growth, and hair quality by dermal cells. J Invest Dermatol. 1993;100(3):229–36.PubMedGoogle Scholar
- Rendl M, Polak L, Fuchs E. BMP signaling in dermal papilla cells is required for their hair follicle-inductive properties. Genes Dev. 2008;22(4):543–57.PubMedPubMed CentralGoogle Scholar
- Inamatsu M, Matsuzaki T, Iwanari H, Yoshizato K. Establishment of rat dermal papilla cell lines that sustain the potency to induce hair follicles from afollicular skin. J Invest Dermatol. 1998;111(5):767–75.PubMedGoogle Scholar
- Kobayashi T, Fujisawa A, Amagai M, Iwasaki T, Ohyama M. Molecular biological and immunohistological characterization of canine dermal papilla cells and the evaluation of culture conditions. Vet Dermatol. 2011;22(5):414–22.PubMedGoogle Scholar
- Soma T, Fujiwara S, Shirakata Y, Hashimoto K, Kishimoto J. Hair-inducing ability of human dermal papilla cells cultured under Wnt/beta-catenin signalling activation. Exp Dermatol. 2012;21(4):307–9.PubMedGoogle Scholar
- Yamauchi K, Kurosaka A. Inhibition of glycogen synthase kinase-3 enhances the expression of alkaline phosphatase and insulin-like growth factor-1 in human primary dermal papilla cell culture and maintains mouse hair bulbs in organ culture. Arch Dermatol Res. 2009;301(5):357–65.PubMedGoogle Scholar
- Inoue K, Aoi N, Yamauchi Y, Sato T, Suga H, Eto H, Kato H, Tabata Y, Yoshimura K. TGF-beta is specifically expressed in human dermal papilla cells and modulates hair folliculogenesis. J Cell Mol Med. 2009;13(11–12):4643–56.PubMedPubMed CentralGoogle Scholar
- Osada A, Iwabuchi T, Kishimoto J, Hamazaki TS, Okochi H. Long-term culture of mouse vibrissal dermal papilla cells and de novo hair follicle induction. Tissue Eng. 2007;13(5):975–82.PubMedGoogle Scholar
- Young TH, Lee CY, Chiu HC, Hsu CJ, Lin SJ. Self-assembly of dermal papilla cells into inductive spheroidal microtissues on poly(ethylene-co-vinyl alcohol) membranes for hair follicle regeneration. Biomaterials. 2008; 29(26):3521–30.Google Scholar
- Higgins CA, Richardson GD, Ferdinando D, Westgate GE, Jahoda CA. Modelling the hair follicle dermal papilla using spheroid cell cultures. Exp Dermatol. 2011;19(6):546–8.Google Scholar
- Kang BM, Kwack MH, Kim MK, Kim JC, Sung YK. Sphere formation increases the ability of cultured human dermal papilla cells to induce hair follicles from mouse epidermal cells in a reconstitution assay. J Invest Dermatol. 2012;132(1):237–9.PubMedGoogle Scholar
- Higgins CA, Itoh M, Inoue K, Richardson GD, Jahoda CA, Christiano AM. Reprogramming of human hair follicle dermal papilla cells into induced pluripotent stem cells. J Invest Dermatol. 2012;132(6):1725–7.PubMedGoogle Scholar
- Woo WM, Zhen HH, Oro AE. Shh maintains dermal papilla identity and hair morphogenesis via a Noggin-Shh regulatory loop. Genes Dev. 2012;26(11):1235–46.PubMedPubMed CentralGoogle Scholar
- Driskell RR, Juneja VR, Connelly JT, Kretzschmar K, Tan DW, Watt FM. Clonal growth of dermal papilla cells in hydrogels reveals intrinsic differences between Sox2-positive and -negative cells in vitro and in vivo. J Invest Dermatol. 2012;132(4):1084–93.PubMedGoogle Scholar
- Grisanti L, Clavel C, Cai X, Rezza A, Tsai SY, Sennett R, Mumau M, Cai CL, Rendl M. Tbx18 targets dermal condensates for labeling, isolation, and gene ablation during embryonic hair follicle formation. J Invest Dermatol. 2013;133(2):344–53.Google Scholar
- Horne KA, Jahoda CA. Restoration of hair growth by surgical implantation of follicular dermal sheath. Development. 1992;116(3):563–71.PubMedGoogle Scholar
- Oliver RF. Histological studies of whisker regeneration in the hooded rat. J Embryol Exp Morphol. 1966;16(2):231–44.PubMedGoogle Scholar
- Rahmani W, Abbasi S, Hagner A, Raharjo E, Kumar R, Hotta A, Magness S, Metzger D, Biernaskie J. Hair follicle dermal stem cells regenerate the dermal sheath, repopulate the dermal papilla, and modulate hair type. Dev Cell. 2014;31(5):543–58.PubMedGoogle Scholar
- Lichti U, Weinberg WC, Goodman L, Ledbetter S, Dooley T, Morgan D, Yuspa SH. In vivo regulation of murine hair growth: insights from grafting defined cell populations onto nude mice. J Invest Dermatol. 1993;101(1 Suppl):124S–9S.PubMedGoogle Scholar
- Biernaskie J, Paris M, Morozova O, Fagan BM, Marra M, Pevny L, Miller FD. SKPs derive from hair follicle precursors and exhibit properties of adult dermal stem cells. Cell Stem Cell. 2009;5(6):610–23.PubMedPubMed CentralGoogle Scholar
- Huang CF, Chang YJ, Hsueh YY, Huang CW, Wang DH, Huang TC, Wu YT, Su FC, Hughes M, Chuong CM, et al. Assembling composite dermal papilla spheres with adipose-derived stem cells to enhance hair follicle induction. Sci Rep. 2016;6(26436):26436.PubMedPubMed CentralGoogle Scholar
- Choi N, Choi J, Kim JH, Jang Y, Yeo JH, Kang J, Song SY, Lee J, Sung JH. Generation of trichogenic adipose-derived stem cells by expression of three factors. J Dermatol Sci. 2018;92(1):18–29.PubMedGoogle Scholar
- Fan SM, Tsai CF, Yen CM, Lin MH, Wang WH, Chan CC, Chen CL, Phua KKL, Pan SH, Plikus MV, et al. Inducing hair follicle neogenesis with secreted proteins enriched in embryonic skin. Biomaterials. 2018;167:121–31.PubMedGoogle Scholar
- Petit I, Kesner NS, Karry R, Robicsek O, Aberdam E, Muller FJ, Aberdam D, Ben-Shachar D. Induced pluripotent stem cells from hair follicles as a cellular model for neurodevelopmental disorders. Stem Cell Res. 2012;8(1):134–40.PubMedGoogle Scholar
- Utikal J, Maherali N, Kulalert W, Hochedlinger K. Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J Cell Sci. 2009;122(Pt 19):3502–10.PubMedPubMed CentralGoogle Scholar
- Tsai SY, Bouwman BA, Ang YS, Kim SJ, Lee DF, Lemischka IR, Rendl M. Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells. Stem Cells. 2011;29(6):964–71.PubMedGoogle Scholar
- Itoh M, Kiuru M, Cairo MS, Christiano AM. Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci U S A. 2011;108(21):8797–802.PubMedPubMed CentralGoogle Scholar
- Itoh M, Umegaki-Arao N, Guo Z, Liu L, Higgins CA, Christiano AM. Generation of 3D skin equivalents fully reconstituted from human induced pluripotent stem cells (iPSCs). PLoS One. 2013;8(10):e77673.PubMedPubMed CentralGoogle Scholar
- Fukuta M, Nakai Y, Kirino K, Nakagawa M, Sekiguchi K, Nagata S, Matsumoto Y, Yamamoto T, Umeda K, Heike T, et al. Derivation of mesenchymal stromal cells from pluripotent stem cells through a neural crest lineage using small molecule compounds with defined media. PLoS One. 2014;9(12):e112291.PubMedPubMed CentralGoogle Scholar
- Hynes K, Menicanin D, Gronthos S, Bartold MP. Differentiation of iPSC to mesenchymal stem-like cells and their characterization. Methods Mol Biol. 2016;1357:353–74.Google Scholar
- Mabuchi Y, Morikawa S, Harada S, Niibe K, Suzuki S, Renault-Mihara F, Houlihan DD, Akazawa C, Okano H, Matsuzaki Y. LNGFR(+)THY-1(+)VCAM-1(hi+) cells reveal functionally distinct subpopulations in mesenchymal stem cells. Stem Cell Reports. 2013;1(2):152–65.PubMedPubMed CentralGoogle Scholar
- Wong CE, Paratore C, Dours-Zimmermann MT, Rochat A, Pietri T, Suter U, Zimmermann DR, Dufour S, Thiery JP, Meijer D, et al. Neural crest-derived cells with stem cell features can be traced back to multiple lineages in the adult skin. J Cell Biol. 2006;175(6):1005–15.PubMedPubMed CentralGoogle Scholar
- Nagoshi N, Shibata S, Kubota Y, Nakamura M, Nagai Y, Satoh E, Morikawa S, Okada Y, Mabuchi Y, Katoh H, et al. Ontogeny and multipotency of neural crest-derived stem cells in mouse bone marrow, dorsal root ganglia, and whisker pad. Cell Stem Cell. 2008;2(4):392–403.PubMedGoogle Scholar
- Ohyama M. Management of hair loss disorders. Dermatol Sinica. 2010;28(4):139–45.Google Scholar
- Chi W, Wu E, Morgan BA. Dermal papilla cell number specifies hair size, shape and cycling and its reduction causes follicular decline. Development. 2013;140(8):1676–83.PubMedPubMed CentralGoogle Scholar
- Yamao M, Inamatsu M, Okada T, Ogawa Y, Ishida Y, Tateno C, Yoshizato K. Restorative effect of hair follicular dermal cells on injured human hair follicles in a mouse model. Exp Dermatol. 2015;24(3):225–7.PubMedGoogle Scholar
- Rajendran RL, Gangadaran P, Bak SS, Oh JM, Kalimuthu S, Lee HW, Baek SH, Zhu L, Sung YK, Jeong SY, et al. Extracellular vesicles derived from MSCs activates dermal papilla cell in vitro and promotes hair follicle conversion from telogen to anagen in mice. Sci Rep. 2017;7(1):15560.PubMedPubMed CentralGoogle Scholar
- Won CH, Park GH, Wu X, Tran TN, Park KY, Park BS, Kim DY, Kwon O, Kim KH. The basic mechanism of hair growth stimulation by adipose-derived stem cells and their secretory factors. Curr Stem Cell Res Ther. 2017;12(7):535–43.PubMedGoogle Scholar
- Higgins CA, Roger MF, Hill RP, Ali-Khan AS, Garlick JA, Christiano AM, Jahoda CAB. Multifaceted role of hair follicle dermal cells in bioengineered skins. Br J Dermatol. 2017;176(5):1259–69.PubMedGoogle Scholar
- Lako M, Armstrong L, Cairns PM, Harris S, Hole N, Jahoda CA. Hair follicle dermal cells repopulate the mouse haematopoietic system. J Cell Sci. 2002;115(Pt 20):3967–74.PubMedGoogle Scholar
- Jahoda CA, Whitehouse J, Reynolds AJ, Hole N. Hair follicle dermal cells differentiate into adipogenic and osteogenic lineages. Exp Dermatol. 2003;12(6):849–59.PubMedGoogle Scholar
- Liu J, Higgins CA, Whitehouse JC, Harris SJ, Crawford H, Christiano AM, Lako M, Hole N, Jahoda CAB. Hair follicle dermal cells support expansion of murine and human embryonic and induced pluripotent stem cells and promote haematopoiesis in mouse cultures. Stem Cells Int. 2018;2018:8631432.PubMedPubMed CentralGoogle Scholar
- Wang X, Hao J, Leung G, Breitkopf T, Wang E, Kwong N, Akhoundsadegh N, Warnock GL, Shapiro J, McElwee KJ. Hair follicle dermal sheath derived cells improve islet allograft survival without systemic immunosuppression. J Immunol Res. 2015;2015:607328.PubMedPubMed CentralGoogle Scholar
- Cotsarelis G. Epithelial stem cells: a folliculocentric view. J Invest Dermatol. 2006;126(7):1459–68.PubMedGoogle Scholar